CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,200,925 | +178.5% | 102,731 | +295.0% | 0.04% | +144.4% |
| Q1 2023 | $431,262 | -12.2% | 26,011 | -32.0% | 0.02% | -41.9% |
| Q3 2022 | $491,000 | +16.4% | 38,274 | -36.5% | 0.03% | +106.7% |
| Q2 2022 | $422,000 | +22.7% | 60,239 | +45.3% | 0.02% | +15.4% |
| Q1 2022 | $344,000 | +319.5% | 41,445 | +169.2% | 0.01% | +160.0% |
| Q3 2021 | $82,000 | -69.1% | 15,395 | -66.6% | 0.01% | -70.6% |
| Q2 2021 | $265,000 | +2.7% | 46,103 | -17.8% | 0.02% | +30.8% |
| Q1 2021 | $258,000 | +486.4% | 56,066 | +324.9% | 0.01% | +550.0% |
| Q4 2020 | $44,000 | -93.3% | 13,196 | -94.0% | 0.00% | -93.5% |
| Q3 2020 | $657,000 | +926.6% | 221,358 | +1387.4% | 0.03% | +244.4% |
| Q1 2015 | $64,000 | – | 14,882 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |